One week after transplantation, tumor incidence was 27% in wild type hosts, but only 7% in Notch4−/− hosts, and two weeks after transplantation, tumor incidence was still significantly reduced in the Notch4−/− hosts (Figure 3). This evidence concerns the gene NOTCH4 and neoplasm.